stock.name

Vericel Corp

VCEL

Market Cap$2.2B
Close$

Compare Vericel

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vericel CorpVericel Corp-6910%-1%11.5-
marketMarket Avg58.91.29%29%-1
HealthcareHealthcare Avg66.31.31%15%-0.9
$51.00

Target Price by Analysts

11.2% upsideVericel Target Price DetailsTarget Price
$3.52

Current Fair Value

92.3% downside

Overvalued by 92.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.20 Billion
Enterprise Value$2.09 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.07
Beta0.0
Outstanding Shares48,380,458
Avg 30 Day Volume353,109

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-691.04
PEG-578.75
Price to Sales11.47
Price to Book Ratio11.47
Enterprise Value to Revenue10.58
Enterprise Value to EBIT-323.23
Enterprise Value to Net Income-657
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Vericel Corp

CEO: Dominick Colangelo